HSD3B1 and overall survival (OS) in men with low-volume (LV) metastatic prostate cancer (PCa) treated with androgen deprivation therapy (ADT) or chemohormonal therapy in the CHAARTED Randomized trial Meeting Abstract
| Authors: | Hearn, J. W. D.; Sweeney, C.; Almassi, N.; Reichard, C. A.; Reddy, C. A.; Hobbs, B.; Jarrard, D. F.; Chen, Y. H.; Dreicer, R.; Garcia, J. A.; Carducci, M. A.; DiPaola, R. S.; Sharifi, N. |
| Abstract Title: | HSD3B1 and overall survival (OS) in men with low-volume (LV) metastatic prostate cancer (PCa) treated with androgen deprivation therapy (ADT) or chemohormonal therapy in the CHAARTED Randomized trial |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 293s |
| Language: | English |
| ACCESSION: | WOS:000487345805428 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.5020 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5020 -- Source: Wos |
